Abstract Cell signaling important for homeostatic regulation of colonic epithelial cells (CECs) remains poorly understood. Mammalian target of rapamycin complex 1 (mTORC1), a protein complex that contains the serine-threonine kinase mTOR, mediates signaling that underlies the control of cellular functions such as proliferation and autophagy by various external stimuli. We here show that ablation of tuberous sclerosis complex 2 (Tsc2), a negative regulator of mTORC1, specifically in intestinal epithelial cells of mice resulted in increased activity of mTORC1 of, as well as increased proliferative activity of, CECs. Such Tsc2 ablation also reduced the population of Lgr5-positive colonic stem cells and the expression of Wnt target genes in CEC...
Tuberous sclerosis complex (TSC) is a rare genetic disorder where patients develop benign tumours in...
Inactivation of APC is a strongly predisposing event in the development of colorectal cancer, prompt...
The mammalian target of rapamycin (mTOR), which exists in two functionally distinct complexes, mTORC...
Background & Aims: Intestinal adaptation is a compensatory response to the massive loss of small int...
Inflammatory bowel disease (IBD) is a chronic condition driven by loss of homeostasis between the mu...
Inflammatory bowel disease (IBD) is a chronic condition driven by loss of homeostasis between the mu...
Epithelial cells lining the intestinal mucosa constitute a selective-semipermeable barrier acting as...
The intestinal mucosa undergoes a continual process of proliferation, differentiation and apoptosis,...
Innate lymphoid cells (ILCs) have a protective immune function at mucosal tissues but can also contr...
Truncating mutations in adenomatous polyposis coli (APC) are strongly linked to colorectal cancers. ...
The inflammatory prostaglandin E2 (PGE2) cytokine plays a key role in the development of colon cance...
The mechanistic target of rapamycin complex 1 (mTORC1) is a signaling hub that senses numerous upstr...
SummaryThe innate inflammatory immune response must be tightly controlled to avoid damage to the hos...
The role of granulocyte-macrophage-colony-stimulating factor-producing T helper (ThGM) cells in colo...
Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapa...
Tuberous sclerosis complex (TSC) is a rare genetic disorder where patients develop benign tumours in...
Inactivation of APC is a strongly predisposing event in the development of colorectal cancer, prompt...
The mammalian target of rapamycin (mTOR), which exists in two functionally distinct complexes, mTORC...
Background & Aims: Intestinal adaptation is a compensatory response to the massive loss of small int...
Inflammatory bowel disease (IBD) is a chronic condition driven by loss of homeostasis between the mu...
Inflammatory bowel disease (IBD) is a chronic condition driven by loss of homeostasis between the mu...
Epithelial cells lining the intestinal mucosa constitute a selective-semipermeable barrier acting as...
The intestinal mucosa undergoes a continual process of proliferation, differentiation and apoptosis,...
Innate lymphoid cells (ILCs) have a protective immune function at mucosal tissues but can also contr...
Truncating mutations in adenomatous polyposis coli (APC) are strongly linked to colorectal cancers. ...
The inflammatory prostaglandin E2 (PGE2) cytokine plays a key role in the development of colon cance...
The mechanistic target of rapamycin complex 1 (mTORC1) is a signaling hub that senses numerous upstr...
SummaryThe innate inflammatory immune response must be tightly controlled to avoid damage to the hos...
The role of granulocyte-macrophage-colony-stimulating factor-producing T helper (ThGM) cells in colo...
Genetic studies have shown that the tuberous sclerosis complex (TSC) 1-TSC2-mammalian target of Rapa...
Tuberous sclerosis complex (TSC) is a rare genetic disorder where patients develop benign tumours in...
Inactivation of APC is a strongly predisposing event in the development of colorectal cancer, prompt...
The mammalian target of rapamycin (mTOR), which exists in two functionally distinct complexes, mTORC...